Generation Bio Inc. (GBIO): Price and Financial Metrics
GBIO Price/Volume Stats
| Current price | $2.45 | 52-week high | $4.65 |
| Prev. close | $2.39 | 52-week low | $0.86 |
| Day low | $2.33 | Volume | 62,935 |
| Day high | $2.48 | Avg. volume | 187,309 |
| 50-day MA | $2.49 | Dividend yield | N/A |
| 200-day MA | $2.72 | Market Cap | 163.00M |
GBIO Stock Price Chart Interactive Chart >
Generation Bio Inc. (GBIO) Company Bio
Generation Bio Co. is a genetic medicines company focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA; a novel cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The company was founded by Mark D. Angelino, Jason P. Rhodes, and Robert M. Kotin in 2016 and is headquartered in Cambridge, MA.
GBIO Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...